As of 2025-03-19, the Relative Valuation of Harmony Biosciences Holdings Inc (HRMY) is 51.65 USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.40 USD, the upside of Harmony Biosciences Holdings Inc based on Relative Valuation is 50.1%.
The range of the Relative Valuation is 41.96 - 61.70 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 24.3x | 20.4x |
| Forward P/E multiples | 18.7x - 21.9x | 19.4x |
| Fair Price | 41.96 - 61.70 | 51.65 |
| Upside | 22.0% - 79.4% | 50.1% |
| Date | P/E |
| 2025-03-17 | 13.53 |
| 2025-03-14 | 12.90 |
| 2025-03-13 | 12.90 |
| 2025-03-12 | 13.24 |
| 2025-03-11 | 13.26 |
| 2025-03-10 | 13.57 |
| 2025-03-07 | 13.27 |
| 2025-03-06 | 13.29 |
| 2025-03-05 | 13.30 |
| 2025-03-04 | 12.85 |
| 2025-03-03 | 12.68 |
| 2025-02-28 | 13.34 |
| 2025-02-27 | 12.91 |
| 2025-02-26 | 13.19 |
| 2025-02-25 | 14.57 |
| 2025-02-24 | 13.47 |
| 2025-02-21 | 13.62 |
| 2025-02-20 | 13.75 |
| 2025-02-19 | 13.92 |
| 2025-02-18 | 15.41 |
| 2025-02-14 | 15.37 |
| 2025-02-13 | 15.40 |
| 2025-02-12 | 14.92 |
| 2025-02-11 | 14.88 |
| 2025-02-10 | 14.97 |
| 2025-02-07 | 14.76 |
| 2025-02-06 | 15.29 |
| 2025-02-05 | 15.51 |
| 2025-02-04 | 15.37 |
| 2025-02-03 | 15.25 |
| 2025-01-31 | 15.28 |
| 2025-01-30 | 15.59 |
| 2025-01-29 | 15.30 |
| 2025-01-28 | 15.14 |
| 2025-01-27 | 15.08 |
| 2025-01-24 | 14.98 |
| 2025-01-23 | 14.98 |
| 2025-01-22 | 15.24 |
| 2025-01-21 | 15.95 |
| 2025-01-17 | 15.39 |
| 2025-01-16 | 15.19 |
| 2025-01-15 | 14.56 |
| 2025-01-14 | 14.36 |
| 2025-01-13 | 14.37 |
| 2025-01-10 | 13.35 |
| 2025-01-08 | 13.61 |
| 2025-01-07 | 13.87 |
| 2025-01-06 | 13.60 |
| 2025-01-03 | 13.71 |
| 2025-01-02 | 13.73 |